Order Article Reprints

Carlone G, Simeone R, Baraldo M, Maestro A, Zanon D, Barbi E, Maximova N. Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients. Journal of Clinical Medicine. 2021; 10(3):406. https://doi.org/10.3390/jcm10030406

Carlone, Giorgia, Roberto Simeone, Massimo Baraldo, Alessandra Maestro, Davide Zanon, Egidio Barbi, and Natalia Maximova. 2021. "Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients" Journal of Clinical Medicine 10, no. 3: 406. https://doi.org/10.3390/jcm10030406

Carlone, G., Simeone, R., Baraldo, M., Maestro, A., Zanon, D., Barbi, E., & Maximova, N. (2021). Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients. Journal of Clinical Medicine, 10(3), 406. https://doi.org/10.3390/jcm10030406